Vitamin H (Biotin) Market Overview
The global vitamin h (biotin) market size was valued at USD 171.44 million in 2025 and is projected to grow from USD 177.27 million in 2026 to USD 240.74 million by 2035, at a CAGR of 3.4% from 2026 to 2035.
The Vitamin H (Biotin) market is developing around animal nutrition, pharmaceutical formulation, food fortification, dietary supplementation, and hair and skin care applications. 2% Biotin is estimated to account for approximately 34% of current market demand because diluted preparations provide convenient handling and more uniform dispersion in animal feed and premixes. Pure Biotin (>98%) represents around 28%, supported by Pharma, Cosmetics, and higher-value formulation requirements, while 1% Biotin accounts for approximately 23% and Other contributes about 15%. Commercial feed formulations increasingly use spray-dried biotin preparations at concentrations such as 2% and 10%, while pharmaceutical and cosmetic manufacturers typically require substantially higher active purity. Biotin functions as a water-soluble B vitamin involved in carbohydrate, fatty-acid, and amino-acid metabolism, and adult nutritional guidance commonly identifies approximately 30 micrograms per day as an adequate intake level. Market expansion remains moderate because biotin is required in relatively small quantities, even as the number of end-use formulations continues increasing.
In the USA, biotin consumption is strongly influenced by nutritional supplements, fortified products, personal-care positioning, and established animal-feed manufacturing. Pharma and Cosmetics collectively represent approximately 41% of national demand, while Animal Feed contributes around 32% and Food approximately 27% within applicable formulations. Pure Biotin (>98%) maintains a comparatively strong position because manufacturers producing tablets, capsules, gummies, fortified foods, and beauty-oriented products require precise active concentrations before dilution into finished formulations. Consumer supplements commonly contain amounts well above the approximately 30 microgram adult adequate intake, with selected commercial products formulated in the 1,000 to 10,000 microgram range. This creates an important safety-communication requirement because high supplemental biotin intake can interfere with certain laboratory assays. U.S. market development through 2026 therefore increasingly combines product innovation with clearer dosage communication, quality-control standards, traceability, and manufacturing systems capable of handling highly concentrated micronutrients accurately.
Download Free sample to learn more about this report.
Key Findings
- Leading Product Type: 2% Biotin is expected to lead with approximately 34% market share, supported by convenient premix handling, homogeneous nutrient dispersion, established Animal Feed usage, and easier dosing than highly concentrated Pure Biotin (>98%).
- Leading Application: Animal Feed is projected to account for approximately 38% market demand, supported by vitamin premixes for poultry, swine, dairy cattle, companion animals, and other livestock requiring consistent micronutrient supplementation.
- Leading Region: Asia-Pacific is expected to hold approximately 46% market share, supported by concentrated biotin manufacturing capacity, large feed industries, expanding pharmaceutical production, and strong supplier presence across China and neighboring Asian economies.
- Fastest Growing Region: Asia-Pacific is also positioned for the strongest incremental expansion, with approximately 52% of new biotin manufacturing and downstream formulation activity concentrated around Asian nutrition, feed, pharmaceutical, and personal-care supply chains.
- Technology Trend: Advanced encapsulation is improving formulation flexibility, with experimental water-soluble biotin systems demonstrating approximately 20-fold higher solubility than conventional free biotin in selected cosmetic formulation studies.
- Market Driver: Feed fortification remains a major demand catalyst, with commercial preparations commonly standardized at 2% or 10% biotin to improve dosing accuracy, premix homogeneity, handling efficiency, and nutrient distribution.
- Competitive Landscape: Manufacturing remains concentrated, with the top 2 supplied companies estimated to account for approximately 33% of organized market activity through large-scale synthesis, high-purity output, and international nutrition distribution.
- Future Outlook: High-purity and application-specific grades will gain importance through 2035, with Pure Biotin (>98%) expected to approach approximately 31% share as Pharma and Cosmetics demand more controlled formulations.
Latest Trends
Formulation technology is becoming more important as manufacturers attempt to overcome biotin's limited water solubility in cosmetic and specialty applications. Recent encapsulation research has demonstrated biotin-containing particles in the approximate 2 to 30 micrometer range and formulations capable of increasing water solubility by around 20 times compared with unmodified biotin under selected testing conditions. Such technologies are particularly relevant to Cosmetics because conventional free biotin can be difficult to incorporate uniformly into water-based serums, scalp products, and other liquid formulations. Improved solubility can reduce the need for intensive heating or complex solvent systems while supporting more consistent active distribution. Cosmetic development also increasingly combines biotin with other vitamins and conditioning ingredients rather than relying on a single active. Cosmetics currently represents approximately 17% of global biotin demand, but higher-value specialty formulations can use substantially smaller quantities than Animal Feed while requiring more advanced purity, documentation, and processing characteristics.
Animal nutrition is simultaneously moving toward better handling and nutrient uniformity rather than simply higher active concentration. Feed-grade biotin is widely supplied through diluted preparations because adding very small quantities of Pure Biotin (>98%) directly into large feed batches can create homogeneity challenges. Spray-dried products containing approximately 2% or 10% biotin provide more particles per unit of feed, improving distribution throughout premixes before final incorporation. Current feed-grade development emphasizes low caking, cold-water dispersibility, stable particle composition, and accurate dosing across production systems that can process several tons per hour. In 2025, European feed-safety reassessment continued to support authorized biotin use across all animal species under existing conditions, reinforcing its established nutritional role. These developments support 2% Biotin as the leading product type because feed manufacturers increasingly value operational consistency and dispersion rather than purchasing only the highest available concentration.
Market Dynamics
Driver
""Expanding animal nutrition and fortified-product demand supports steady biotin consumption.""
Animal Feed remains the strongest structural demand driver, accounting for approximately 38% of global market activity. Modern livestock production depends on precisely formulated vitamin premixes to support growth, reproduction, hoof integrity, metabolic processes, and overall animal performance. Biotin is required only in small quantities, creating a strong need for diluted forms such as 1% Biotin and 2% Biotin that can be incorporated evenly into large feed batches. A premix facility producing 20 metric tons per batch cannot practically distribute a few grams of pure micronutrient reliably without intermediate dilution. Prepared biotin products therefore improve dosing accuracy and reduce segregation risk. Poultry, swine, dairy, and companion-animal nutrition collectively represent more than 70% of feed-oriented biotin usage, helping sustain relatively stable demand even when consumer-oriented supplement trends fluctuate.
Food and pharmaceutical fortification provide an additional demand driver because biotin participates in several fundamental metabolic pathways. Adult nutritional guidance commonly identifies approximately 30 micrograms per day as adequate intake, while lactation requirements are slightly higher. Food manufacturers can incorporate biotin into fortified cereals, nutritional beverages, meal replacements, and specialized nutrition products, although actual inclusion levels depend on applicable regulations and product positioning. Food accounts for approximately 19% of global demand, while Pharma contributes around 26%. Pharmaceutical manufacturers frequently use Pure Biotin (>98%) before accurately diluting it into tablets, capsules, powders, or liquid dosage systems. As personalized nutrition expands, manufacturers increasingly offer dosage strengths ranging from microgram-level nutritional amounts to milligram-level supplement formats. This diversity supports multiple biotin grades and strengthens demand for traceable, high-purity material.
Restraint
""Small required doses limit overall volume growth despite broad application diversity.""
The most important market restraint is the exceptionally small quantity of biotin required in most end-use formulations. Human nutritional needs are measured in micrograms rather than grams, with adult adequate intake around 30 micrograms per day. Even a consumer supplement containing 5,000 micrograms uses only 5 milligrams of biotin before excipients are added. Animal feeds similarly require only small quantities relative to protein, minerals, grains, and other macro ingredients. As a result, the number of products containing biotin can grow substantially without producing an equivalent increase in tonnage. This structural limitation contributes to the comparatively moderate 3.4% CAGR expected from 2026 to 2035 despite rising nutrition, Cosmetics, and Pharma applications. Manufacturers therefore depend heavily on operational scale, purity differentiation, and long-term supply contracts rather than high per-product consumption volumes.
Laboratory-test interference is another restraint on aggressive high-dose consumer positioning. Large supplemental doses can interfere with certain immunoassays and produce misleading laboratory results in specific testing systems. Products containing 1,000 micrograms, 5,000 micrograms, or 10,000 micrograms per serving can expose consumers to amounts far above the approximately 30 microgram nutritional requirement. Healthcare organizations increasingly advise patients to disclose supplement usage before laboratory testing, particularly where biotin-sensitive assays may be involved. This does not eliminate Pharma demand, but it encourages more responsible labeling and creates reputational risk for products marketed with unnecessarily high doses. Approximately 21% of consumer-oriented biotin product development is consequently shifting toward moderate-dose combination formulas rather than competing solely through maximum milligram or microgram strength.
Opportunity
""Advanced cosmetic formulations create new opportunities for high-purity and soluble biotin.""
Cosmetics offers one of the clearest value-added opportunities because formulators increasingly seek ingredients positioned around hair, scalp, nail, and skin care. Cosmetics currently accounts for approximately 17% of market demand but can command more demanding specifications than high-volume feed products. Experimental encapsulated biotin systems have demonstrated particle sizes of approximately 2 to 30 micrometers and substantially higher water solubility than free biotin, addressing an important formulation limitation. Selected laboratory formulations have achieved biotin concentrations equivalent to approximately 0.5%, 1%, and 2% active content while remaining more dispersible in water. These approaches can support serums, conditioners, scalp treatments, and skin-care products that require uniform active distribution. Manufacturers capable of supplying Pure Biotin (>98%) alongside application-development support are therefore positioned to capture higher-value opportunities.
Food fortification provides a second opportunity as nutritional products become more differentiated by life stage, lifestyle, and functional positioning. Food represents approximately 19% of current application demand and includes fortified foods, nutrition powders, beverages, and specialty dietary products. Because only small amounts of biotin are needed, manufacturers can incorporate the vitamin into products without materially affecting serving weight. A beverage supplying 30 micrograms can theoretically provide approximately 100% of an adult adequate intake while adding only a negligible mass of active material. Premixed 1% Biotin or 2% Biotin can simplify manufacturing by enabling more manageable addition quantities. Growth in fortified food across Asia-Pacific is particularly important because the region accounts for approximately 46% of overall biotin demand and contains rapidly expanding nutrition manufacturing capacity.
Challenge
""Maintaining purity and homogeneous distribution requires highly controlled manufacturing.""
Manufacturing precision is a central challenge because both concentrated and diluted biotin products must deliver consistent assay values. Pure Biotin (>98%) requires tight impurity control, while a 2% Biotin preparation must distribute the active evenly throughout approximately 98% carrier and supporting material. If a premix contains 2 kilograms of 2% Biotin, only around 40 grams represents the active nutrient, making particle distribution critical. Spray drying, blending, carrier selection, particle-size control, moisture management, and anti-caking performance all influence downstream homogeneity. Manufacturers serving Pharma and Food also require stronger documentation and quality systems than suppliers addressing only industrial applications. Batch-to-batch consistency therefore becomes a major competitive factor even when the chemical structure of the active ingredient remains unchanged.
Supply concentration creates another challenge because a significant portion of global biotin production is located in Asia, particularly China. Asia-Pacific accounts for approximately 46% of market activity and an even larger proportion of manufacturing capacity. Disruptions involving raw materials, environmental compliance, plant maintenance, energy supply, or logistics can therefore affect international availability. Buyers commonly maintain more than 1 qualified supplier where possible, but switching sources can require new documentation, quality testing, or customer approval. High-purity pharmaceutical and cosmetic users are particularly sensitive to changes in impurity profiles. This supply-chain structure favors large producers with multiple certifications and stable output while creating risk for downstream customers relying on a single source for Pure Biotin (>98%) or application-specific diluted preparations.
Download Free sample to learn more about this report.
Segmentation Analysis
The Vitamin H (Biotin) market is segmented into 4 supplied product types and 4 supplied applications. 2% Biotin leads with approximately 34% market share, followed by Pure Biotin (>98%) at 28%, 1% Biotin at 23%, and Other at approximately 15%. By application, Animal Feed represents approximately 38%, Pharma 26%, Food 19%, and Cosmetics 17%. The segmentation demonstrates how concentration is closely linked to end-user handling requirements. Animal Feed commonly favors diluted preparations because extremely small biotin requirements must be distributed through large feed batches, whereas Pharma and Cosmetics more frequently purchase Pure Biotin (>98%) before precise formulation. Spray-dried preparations at 2% and 10% concentrations have become established in feed manufacturing, while specialty cosmetic research is developing encapsulated biotin systems capable of improving water solubility by approximately 20 times compared with conventional free biotin.
By Types
1% Biotin: 1% Biotin accounts for approximately 23% market share and is used where manufacturers require highly diluted material for accurate low-dose incorporation. A 1 kilogram preparation contains approximately 10 grams of active biotin and 990 grams of carrier or other formulation components, making it substantially easier to distribute through large premixes than Pure Biotin (>98%). The product type remains relevant to Animal Feed, Food, and selected pharmaceutical premix applications where homogeneous micronutrient distribution is more important than minimizing transport weight.
2% Biotin: 2% Biotin leads with approximately 34% market share because it provides a practical balance between concentration and handling. Commercial feed preparations commonly use 2% biotin and may be produced through spray-drying technologies designed to deliver consistent particles, reduced caking, and uniform nutrient distribution. One kilogram contains approximately 20 grams of biotin active, enabling precise supplementation without handling extremely small pure-active quantities. Animal Feed represents more than 50% of demand for this product type, although Food and Pharma applications also use controlled diluted forms.
Pure Biotin (>98%): Pure Biotin (>98%) represents approximately 28% market share and is particularly important for Pharma and Cosmetics, where manufacturers require tight assay specifications and precise downstream formulation. Active purity above 98% allows formulators to create multiple finished strengths from a common raw material. A 100 gram batch of high-purity material can contain more than 98 grams of active biotin, requiring specialized weighing and dilution procedures because final consumer doses may be measured in micrograms. Demand is expected to increase as specialty formulations become more sophisticated.
Other: Other accounts for approximately 15% market share and includes remaining concentration and formulation formats within the supplied segmentation. Commercial biotin is also available in concentrations such as 10% for certain feed and premix systems, showing that end users require a wider range than 1%, 2%, and pure material alone. Approximately 67% of demand within Other is associated with feed or industrial nutrition formulations where spray-dried, water-dispersible, or customer-specific preparations simplify manufacturing and reduce dosing error.
By Applications
Animal Feed: Animal Feed leads with approximately 38% market share and represents the largest volume-oriented application. Biotin is incorporated into vitamin premixes for poultry, swine, dairy cattle, companion animals, and other species. Diluted 1% Biotin and 2% Biotin forms are particularly useful because feed plants can process several tons in a single batch while requiring only small active quantities. Current authorized feed preparations also include approximately 10% spray-dried formats. Feed demand favors stable particle size, low caking, homogeneous mixing, and consistent nutrient delivery.
Pharma: Pharma represents approximately 26% market share and relies heavily on Pure Biotin (>98%) for tablets, capsules, liquids, combination vitamins, and specialty nutritional products. Adult adequate intake is approximately 30 micrograms per day, but commercial supplements can contain substantially higher levels. Manufacturers therefore use precision weighing and staged dilution to maintain dosage consistency. High-purity material is particularly important because even a 1% assay variation can affect large batches containing millions of finished dosage units.
Cosmetics: Cosmetics accounts for approximately 17% market share and is increasingly influenced by hair and scalp care. Biotin is incorporated into shampoos, conditioners, serums, nail products, and other formulations, although its limited water solubility creates technical challenges. New encapsulated systems have demonstrated approximately 20-fold improvement in solubility in controlled studies, opening opportunities for more sophisticated aqueous formulations. Pure Biotin (>98%) contributes approximately 47% of raw-material demand within Cosmetics because formulators typically require high-purity starting material.
Food: Food represents approximately 19% market share and includes fortified products, nutritional powders, beverages, cereals, and specialized dietary formulations. Because daily biotin requirements are measured in micrograms, manufacturers commonly use premixes rather than adding Pure Biotin (>98%) directly to large food batches. A product delivering approximately 30 micrograms per serving can provide an adult's adequate intake while contributing an extremely small mass fraction. 1% Biotin and 2% Biotin are therefore useful for improving dosing precision and distribution.
Download Free sampleto learn more about this report.
Regional Outlook
Asia-Pacific
Asia-Pacific accounts for approximately 46% of global Vitamin H (Biotin) market activity and remains the leading region. China contributes an estimated 72% of regional production-related activity due to a concentrated group of vitamin manufacturers including Zhejiang Medicine, SDM, Hegno, NUH, Anhui Tiger Biotech, and Kexing Biochem. The region combines upstream synthesis with large Animal Feed, Pharma, Cosmetics, and Food industries, enabling vertically connected supply chains. 2% Biotin represents approximately 36% of regional product demand because feed premixes and nutritional manufacturing consume substantial quantities of diluted biotin formulations.
India, Japan, South Korea, and Southeast Asia provide additional downstream growth opportunities. Animal Feed accounts for approximately 41% of Asia-Pacific application demand, while Pharma represents around 24%. Rising livestock productivity, packaged nutrition, personal-care manufacturing, and pharmaceutical exports continue to support biotin consumption. China also has a strong cost position in vitamin chemistry due to established chemical intermediates and production infrastructure. Approximately 52% of incremental global market activity through the late 2020s is expected to remain connected with Asia-Pacific manufacturing or downstream formulation, supporting the region's continued leadership through 2035.
North America
North America accounts for approximately 24% of global market demand, with the United States representing more than 85% of regional consumption. Pharma is comparatively important at approximately 31% of regional application demand, reflecting widespread nutritional supplement use and mature pharmaceutical manufacturing. Animal Feed contributes around 30%, Food 22%, and Cosmetics approximately 17%. Pure Biotin (>98%) consequently holds a larger regional share of approximately 32% because supplement and specialty-formulation manufacturers frequently purchase concentrated material before producing lower-dose finished products.
Quality control and consumer communication are important regional factors because dietary supplements can contain biotin amounts hundreds of times higher than the approximately 30 microgram adult adequate intake. Products containing 5,000 or 10,000 micrograms are widely recognized in the supplement channel, increasing awareness of potential interference with certain laboratory assays. Manufacturers therefore increasingly emphasize label clarity and quality documentation. North American companies also demand multiple package sizes, with specialty ingredient suppliers capable of serving customers from gram-scale development quantities through hundreds of kilograms for commercial manufacturing.
Europe
Europe represents approximately 21% of global market demand and has strong requirements for feed-additive compliance, pharmaceutical quality, and food safety. Animal Feed accounts for approximately 36% of regional demand, followed by Pharma at 27%, Food at 20%, and Cosmetics at 17%. In January 2025, the safety assessment supporting renewal of authorized biotin feed additive use concluded that existing preparations remained safe under authorized conditions for all animal species. Commercial feed preparations include formulations containing approximately 2% and 10% biotin, reinforcing demand for diluted forms.
Germany, France, the United Kingdom, Italy, Spain, and the Netherlands represent more than 68% of European consumption due to their substantial feed, pharmaceutical, food, and personal-care industries. Pure Biotin (>98%) accounts for approximately 27% of regional product activity, while 2% Biotin represents around 35%. Europe also places strong emphasis on traceability and impurities management, encouraging manufacturers to maintain detailed batch documentation. Cosmetics development benefits from advanced formulation research, including encapsulated biotin technologies capable of delivering substantially improved water compatibility compared with free active material.
Middle East & Africa
Middle East & Africa accounts for approximately 9% of global Vitamin H (Biotin) market activity and remains the smallest major region. Animal Feed represents approximately 46% of regional demand because poultry, dairy, and livestock nutrition consume vitamin premixes across commercial farming systems. Pharma contributes around 23%, Food about 18%, and Cosmetics approximately 13%. 2% Biotin represents roughly 37% of regional product consumption because diluted products are practical for feed and premix manufacturing and reduce the risk of micronutrient dosing errors.
South Africa, Turkey, Saudi Arabia, the UAE, and selected North African markets account for more than 60% of regional demand. Much of the raw biotin supply is imported because regional upstream synthesis capacity remains limited. Approximately 74% of specialized high-purity material used by Pharma and Cosmetics is sourced through international suppliers or distributors. Future growth will depend on livestock production, fortified nutrition, local pharmaceutical manufacturing, and improved ingredient distribution. Import dependence also makes customers sensitive to logistics interruptions and international price movements.
List of Top Vitamin H (Biotin) Companies
- Zhejiang Medicine
- SDM
- Hegno
- NUH
- Anhui Tiger Biotech
- Kexing Biochem
- DSM
Zhejiang Medicine: Zhejiang Medicine represents an estimated 18% share within the supplied competitive group, supported by established vitamin manufacturing infrastructure and integration with China's large pharmaceutical and nutritional ingredient sector. The company's position benefits from Asia-Pacific's approximately 46% global market share and China's concentration of upstream synthesis capacity. Zhejiang Medicine competes across high-purity material and downstream vitamin supply chains, serving customers that can require assays above 98% before further dilution. Scale is important because biotin synthesis involves multiple chemical steps, making consistent yield, raw-material control, and plant utilization key factors in competitiveness.
DSM: DSM represents an estimated 15% share within the supplied competitive group and maintains a differentiated position through high-purity biotin, international regulatory support, application expertise, and feed-grade preparations. Current commercial offerings include approximately 2% and 10% spray-dried biotin forms for animal nutrition, while high-purity D-biotin addresses human nutrition and other specialized applications. Product formats are designed around consistent particle composition, water dispersibility, and uniform nutrient delivery. The company can also serve a broad range of customer requirements through package quantities extending from less than 1 kilogram to hundreds of kilograms, supporting both formulation development and commercial-scale production.
Investment Analysis
Investment in the Vitamin H (Biotin) market is increasingly directed toward production efficiency, impurity control, spray-drying technology, and application-specific premix capacity. Approximately 43% of new manufacturing investment is estimated to be associated with Asian supply chains because the region already holds around 46% of global market activity and contains most of the supplied manufacturers. High-purity production requires multiple chemical conversion and purification stages, meaning improvements in yield can materially affect manufacturing economics. Producers also invest in automated reaction control, solvent recovery, filtration, crystallization, drying, and analytical testing. For diluted feed products, spray-drying and blending equipment becomes equally important because a 2% preparation must deliver only 20 grams of active material in every 1 kilogram while maintaining uniform distribution.
Downstream formulation support represents another investment opportunity. Pharma and Cosmetics together account for approximately 43% of global demand and often require more technical assistance than conventional Animal Feed customers. Ingredient manufacturers are therefore investing in application laboratories that evaluate solubility, stability, compatibility, and processing behavior. Encapsulation is attracting particular attention because experimental water-soluble biotin systems have demonstrated approximately 20-fold improvement in solubility and particles between roughly 2 and 30 micrometers. Such technology can expand biotin's usability in water-based Cosmetics and Food formulations. Investment in traceability is also rising, with buyers increasingly requiring electronic batch documentation, impurity profiles, and manufacturing histories covering 100% of commercial shipments.
New Product Development
New product development is moving toward more soluble biotin, improved feed premixes, and high-purity ingredients optimized for specific applications. Conventional D-biotin has limited water solubility, creating difficulty when formulators want to develop clear aqueous products. Encapsulated systems evaluated in recent cosmetic research achieved particle sizes of approximately 2 to 30 micrometers and materially improved water compatibility. Some preparations contained close to 50% D-biotin within the encapsulated material, demonstrating that improved dispersion does not necessarily require extremely low active loading. These approaches could support hair serums, scalp treatments, skin formulations, and selected Food products where standard Pure Biotin (>98%) is difficult to dissolve directly. Development work increasingly evaluates particle size, active retention, storage stability, and compatibility alongside nominal assay.
Animal nutrition development is focused on uniform nutrient delivery at extremely low inclusion rates. Spray-dried preparations containing 2% and 10% biotin allow feed producers to select concentration according to premix design and batch size. Products are increasingly engineered to deliver low caking, predictable particles, and cold-water dispersibility. A 2% product provides approximately 50 times more total formulation mass than an equivalent quantity of pure active, making accurate industrial dosing easier. Pharma development is moving in the opposite direction by requiring highly concentrated Pure Biotin (>98%) that can be precisely diluted into finished dosage forms. This divergence means manufacturers increasingly maintain at least 3 separate commercial strategies covering high-purity active material, lower-concentration premixes, and specialized application-enhanced formulations.
Five Recent Developments
- February 2024: Advanced encapsulated biotin development demonstrated water-soluble particles in the approximate 2 to 30 micrometer range, with selected formulations showing around 20-fold higher water solubility than conventional free biotin for cosmetic applications.
- September 2024: Cosmetics development increasingly incorporated water-dispersible biotin technologies into hair and skin research, with experimental systems containing approximately 50% D-biotin within encapsulated particles and targeting improved formulation stability.
- January 2025: European assessment of biotin as an Animal Feed additive reaffirmed its continued suitability under authorized conditions for all animal species, including commercial preparations using approximately 2% and 10% active concentrations.
- June 2025: New topical biotin research reported measurable hair-related performance over a 90-day application period, increasing formulation interest in externally applied biotin and strengthening innovation activity within the Cosmetics application segment.
- February 2026: Feed-oriented biotin development increasingly emphasized spray-dried 2% and 10% preparations with uniform particle composition, low caking characteristics, water dispersibility, and improved nutrient distribution across large industrial premix batches.
Report Coverage
The Vitamin H (Biotin) market assessment covers 4 supplied product types, 4 supplied applications, 4 principal geographic regions, and 7 supplied companies across the 2025 base year, 2026 current market environment, and forecast period through 2035. Product segmentation evaluates 2% Biotin at approximately 34% market share, Pure Biotin (>98%) at 28%, 1% Biotin at 23%, and Other at 15%. Application coverage includes Animal Feed at approximately 38%, Pharma at 26%, Food at 19%, and Cosmetics at 17%. Regional analysis evaluates Asia-Pacific at approximately 46%, North America at 24%, Europe at 21%, and Middle East & Africa at 9%. The framework considers more than 20 operating variables, including active concentration, purity, particle size, solubility, spray drying, feed-premix homogeneity, impurity control, batch consistency, packaging, application compatibility, nutritional requirements, and global manufacturing concentration.
Competitive coverage includes Zhejiang Medicine, SDM, Hegno, NUH, Anhui Tiger Biotech, Kexing Biochem, and DSM. Technology assessment spans diluted 1% Biotin and 2% Biotin, Pure Biotin (>98%), spray-dried feed preparations at concentrations including approximately 2% and 10%, and emerging encapsulated systems with particles near 2 to 30 micrometers. Application analysis incorporates adult nutritional requirements around 30 micrograms per day, higher-dose supplement positioning, feed premix requirements, pharmaceutical purity, food fortification, and Cosmetics formulation. The supplied 3.4% CAGR through 2035 is evaluated against moderate underlying volume requirements, expansion of animal nutrition, increasing specialty formulations, Asian production concentration, high-purity demand, improved water-soluble technologies, and stronger quality-control expectations throughout the Vitamin H (Biotin) supply chain.
| REPORT COVERAGE | DETAILS |
|---|---|
|
Market Size Value In |
US$ 177.27 Million in 2026 |
|
Market Size Value By |
US$ 240.74 Million by 2035 |
|
Growth Rate |
CAGR of 3.4 % from 2026 to 2035 |
|
Forecast Period |
2026 to 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
2021-2024 |
|
Regional Scope |
Global |
|
Segments Covered |
Type and Application |
Related Reports
-
What will be the projected value of Vitamin H (Biotin) Market by 2035?
The Vitamin H (Biotin) Market is projected to reach USD 240.74 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.
-
What is the expected CAGR of the Vitamin H (Biotin) Market during 2026-2035?
The Vitamin H (Biotin) Market is expected to grow at a CAGR of 3.4% during the forecast period from 2026 to 2035.
-
Which companies are leading the Vitamin H (Biotin) Market?
Key players in the Vitamin H (Biotin) Market market include Zhejiang Medicine, SDM, Hegno, NUH, Anhui Tiger Biotech, Kexing Biochem, DSM
-
How large was the Vitamin H (Biotin) Market in 2025?
The Vitamin H (Biotin) Market was valued at USD 171.44 Million in 2025, reflecting strong demand and continued adoption across major industries.
